MPO and endothelial dysfunction: The free radical HOCl Is a major product of myeloperoxidase, an enzyme in atherosclerotic lesions that contributes to atherogenic lipoprotein dysfunction, reduced NO bioavailability, endothelial dysfunction, impaired vasoreactivity, and increased atherosclerotic plaque instability [133,134].